Steele Capital Management, Inc. Abbott Laboratories Transaction History
Steele Capital Management, Inc.
- $1.79 Trillion
- Q2 2024
A detailed history of Steele Capital Management, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Steele Capital Management, Inc. holds 9,217 shares of ABT stock, worth $1.09 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
9,217
Previous 9,617
4.16%
Holding current value
$1.09 Million
Previous $1.09 Billion
12.38%
% of portfolio
0.05%
Previous 0.06%
Shares
3 transactions
Others Institutions Holding ABT
# of Institutions
3,173Shares Held
1.33BCall Options Held
8.62MPut Options Held
7.18M-
Vanguard Group Inc Valley Forge, PA166MShares$19.6 Billion0.34% of portfolio
-
Black Rock Inc. New York, NY131MShares$15.4 Billion0.31% of portfolio
-
State Street Corp Boston, MA74.4MShares$8.76 Billion0.34% of portfolio
-
Capital International Investors Los Angeles, CA71.8MShares$8.45 Billion1.57% of portfolio
-
Capital Research Global Investors Los Angeles, CA57.2MShares$6.74 Billion1.34% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $206B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...